Evaluation and Treatment of Anemia in Premature Infants

Edo Hasanbegovic1, Nermana Cengic1, Snijezana Hasanbegovic1

  • 1Pediatric Clinic, University Clinical Center Sarajevo, Sarajevo, Bosnia and Herzegovina.

Insights

Anemia in preterm infants, especially those born at ≤ 32 weeks, frequently requires blood transfusions. These transfusions are linked to an increased risk of intracranial bleeding in the first week of life.

Area of Science:

  • Neonatal Medicine
  • Pediatric Hematology
  • Clinical Research

Background:

  • Anemia in preterm infants involves rapid hemoglobin decline, necessitating transfusions and erythropoietin.
  • Physiological anemia in full-term infants differs significantly from preterm anemia.

Purpose of the Study:

  • Determine anemia frequency in preterm infants at University Clinical Center Sarajevo.
  • Analyze blood count parameters and their relation to blood transfusions.
  • Investigate the link between blood transfusions and intraventricular hemorrhage in preterm infants.

Main Methods:

  • Retrospective study over six months in 2014.
  • Included 100 preterm infants (gestational age < 37 weeks).
  • Data collected from medical records at the Pediatric Clinic, UCCS.

Main Results:

  • Two groups: ≤ 32 weeks (62%) and 33-37 weeks (38%).
  • Significant differences in birth weight, APGAR scores, and mortality rates between groups.
  • Infants ≤ 32 weeks showed a higher need for blood transfusions (18 vs. 3 patients).

Conclusions:

  • Preterm infants with gestational age ≤ 32 weeks have a higher likelihood of requiring blood transfusions.
  • Early blood transfusions (first week of life) in very preterm infants are associated with an increased risk of intracranial bleeding.
Abstract